Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain

COVID-19 vaccines have shown high efficacy, with most side effects being mild–moderate and more frequently reported by females and people at younger ages. Since no studies have assessed the impact that weight status could have on the reported adverse reactions, we aim to study the association betwee...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Isabel Iguacel, Aurelio Luna Maldonado, Aurelio Luna Ruiz-Cabello, Marta Casaus, Luis Alberto Moreno, Begoña Martínez-Jarreta
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/c0de24d36791409583c373aa57a3377a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c0de24d36791409583c373aa57a3377a
record_format dspace
spelling oai:doaj.org-article:c0de24d36791409583c373aa57a3377a2021-11-25T19:11:18ZAssociation between COVID-19 Vaccine Side Effects and Body Mass Index in Spain10.3390/vaccines91113212076-393Xhttps://doaj.org/article/c0de24d36791409583c373aa57a3377a2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1321https://doaj.org/toc/2076-393XCOVID-19 vaccines have shown high efficacy, with most side effects being mild–moderate and more frequently reported by females and people at younger ages. Since no studies have assessed the impact that weight status could have on the reported adverse reactions, we aim to study the association between weight status and reported side effects. We included data on 2136 adults from an online survey conducted from 6 May to 9 June 2021. The questionnaire was filled in by participants over Google forms. Generalized Linear Mixed Models were used. A higher risk of presenting fever ≥38°, vomiting, diarrhea and chills was found in those with a non-overweight status compared to those overweight after adjusting for age, sex, education, medication to prevent/relieve post-vaccination effects and vaccine administered. When adjusting, most of the significant effects, in the association between side effects of the COVID-19 vaccine and weight status, did not remain significant. In conclusion, a non-overweight status was associated with a higher risk of presenting fever ≥38°, vomiting, diarrhea and chills compared to those overweight. Nevertheless, most of the reported side effects to COVID-19 vaccine were not associated with a higher risk of presenting more adverse effects, and individual differences were determined by sex and age.Isabel IguacelAurelio Luna MaldonadoAurelio Luna Ruiz-CabelloMarta CasausLuis Alberto MorenoBegoña Martínez-JarretaMDPI AGarticleSARS CoV-2vaccinationoverweightobesityvaccine adverse eventsMedicineRENVaccines, Vol 9, Iss 1321, p 1321 (2021)
institution DOAJ
collection DOAJ
language EN
topic SARS CoV-2
vaccination
overweight
obesity
vaccine adverse events
Medicine
R
spellingShingle SARS CoV-2
vaccination
overweight
obesity
vaccine adverse events
Medicine
R
Isabel Iguacel
Aurelio Luna Maldonado
Aurelio Luna Ruiz-Cabello
Marta Casaus
Luis Alberto Moreno
Begoña Martínez-Jarreta
Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
description COVID-19 vaccines have shown high efficacy, with most side effects being mild–moderate and more frequently reported by females and people at younger ages. Since no studies have assessed the impact that weight status could have on the reported adverse reactions, we aim to study the association between weight status and reported side effects. We included data on 2136 adults from an online survey conducted from 6 May to 9 June 2021. The questionnaire was filled in by participants over Google forms. Generalized Linear Mixed Models were used. A higher risk of presenting fever ≥38°, vomiting, diarrhea and chills was found in those with a non-overweight status compared to those overweight after adjusting for age, sex, education, medication to prevent/relieve post-vaccination effects and vaccine administered. When adjusting, most of the significant effects, in the association between side effects of the COVID-19 vaccine and weight status, did not remain significant. In conclusion, a non-overweight status was associated with a higher risk of presenting fever ≥38°, vomiting, diarrhea and chills compared to those overweight. Nevertheless, most of the reported side effects to COVID-19 vaccine were not associated with a higher risk of presenting more adverse effects, and individual differences were determined by sex and age.
format article
author Isabel Iguacel
Aurelio Luna Maldonado
Aurelio Luna Ruiz-Cabello
Marta Casaus
Luis Alberto Moreno
Begoña Martínez-Jarreta
author_facet Isabel Iguacel
Aurelio Luna Maldonado
Aurelio Luna Ruiz-Cabello
Marta Casaus
Luis Alberto Moreno
Begoña Martínez-Jarreta
author_sort Isabel Iguacel
title Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
title_short Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
title_full Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
title_fullStr Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
title_full_unstemmed Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
title_sort association between covid-19 vaccine side effects and body mass index in spain
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/c0de24d36791409583c373aa57a3377a
work_keys_str_mv AT isabeliguacel associationbetweencovid19vaccinesideeffectsandbodymassindexinspain
AT aureliolunamaldonado associationbetweencovid19vaccinesideeffectsandbodymassindexinspain
AT aureliolunaruizcabello associationbetweencovid19vaccinesideeffectsandbodymassindexinspain
AT martacasaus associationbetweencovid19vaccinesideeffectsandbodymassindexinspain
AT luisalbertomoreno associationbetweencovid19vaccinesideeffectsandbodymassindexinspain
AT begonamartinezjarreta associationbetweencovid19vaccinesideeffectsandbodymassindexinspain
_version_ 1718410239909298176